TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06082362

Intervention type: OTHER
Intervention: Collection of clinical and biological material
Description: Collection of clinical and biological material (e.g., samples of semen, stool, urine, blood, buccal swab)

Intervention type: OTHER
Intervention: Collection of clinical and biological material
Description: Collection of clinical and biological material (e.g., samples of semen, stool, urine, blood, buccal swab)

Intervention type: OTHER
Intervention: Collection of clinical and biological material
Description: Collection of clinical and biological material (e.g., samples of semen, stool, urine, blood, buccal swab)
Study: NCT04885998

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tarlatamab
Description: Tarlatamab will be administered as an intravenous (IV) infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tarlatamab
Description: Tarlatamab will be administered as an intravenous (IV) infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 404
Description: AMG 404 will be administered as an intravenous (IV) infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMG 404
Description: AMG 404 will be administered as an intravenous (IV) infusion.
Study: NCT05310240

Intervention type: PROCEDURE
Intervention: Hip arthroscopy
Description: Arthroscopic surgery of the hip
Study: NCT04788329

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prepare for Surgery, Heal Faster Program
Description: This NYU program teaches patients how to feel calmer before surgery. Patients are taught relaxation techniques by phone or in person by trained NYU personnel. The program uses five steps to ease stress-related symptoms prior to surgery and improve help recovery time. By practicing deep relaxation, it is possible to reduce anxiety and promote a feeling of calmness. The patient swill be enrolled in the course preoperatively and will be ask to continue these meditations for ten weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wim Hof Method
Description: Patients will be enrolled in Wim Hof Method, a breathing/meditation program. This is a free online program, developed by a man named Wim Hof and his techniques. On this website, he explains the origins and methods behind his teachings ( https://www.wimhofmethod.com/iceman-wim-hof. ). Patients in this group will take the online free course provided by the Wim Hof Method. The patients will be introduced to the online course preoperatively. The three pillars of the WHM are 1) breathing/meditation, 2) stretching exercises and 3) gradual cold exposure. The patients will be told to concentrate on the breathing and meditation component, they may not be able to participate in the cold exposure (cold showers, ice baths) in the immediate post op period because of the open wounds.
Study: NCT06390436

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood sample
Description: A blood sample will be taken, in addition to blood samples taken for the usual follow-up, with 4 dry tubes for the determination of ADA and anti-ADA antibodies and for bio-collection.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood sample
Description: A blood sample will be taken, in addition to blood samples taken for the usual follow-up, with 4 dry tubes for the determination of ADA and anti-ADA antibodies and for bio-collection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adalimumab Injection
Description: Adalimumab Injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adalimumab Injection
Description: Adalimumab Injection
Study: NCT04963010

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: second forward view
Description: second forward view examination of the proximal colon
Study: NCT04902976

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CPC+ZN
Description: In patients hospitalized in common beds, and without mechanical ventilation, the it will be asked to perform the following procedures: mouth rinse with 20 mL of the solution for 30 s

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CPC
Description: In patients hospitalized in common beds, and without mechanical ventilation, the it will be asked to perform the following procedures: mouth rinse with 20 mL of the proposed solution for 30 s;

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Negative Control
Description: In patients hospitalized in common beds, and without mechanical ventilation, the it will be asked to perform the following procedures: mouth rinse with 20 mL of distilled water for 30 s.
Study: NCT05056233

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systane Hydration lubricant eye drops
Description: Sterile solution indicated for the temporary relief of burning and irritation due to dryness of the eye
Study: NCT06019702

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: iNeo-Vac-R01
Description: Personalized mRNA vaccine encoding neoantigen, IH injection
Study: NCT03990961

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Subjects will receive pembrolizumab treatment at a dose of 200mg IV every 3 weeks for a duration of 2 years (35 cycles).
Study: NCT05607381

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meditation
Description: Participants will complete 8 sessions of meditation training with therapy as a means of coping with chronic pain and opioid-related issues.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meditation
Description: Participants will complete 8 sessions of meditation training with therapy as a means of coping with chronic pain and opioid-related issues.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Participants will receive usual care for chronic low back pain (e.g., analgesic medication, pain management consultant from a physician, physical therapy, etc.).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Participants will receive usual care for chronic low back pain (e.g., analgesic medication, pain management consultant from a physician, physical therapy, etc.).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Participants will receive usual care for chronic low back pain (e.g., analgesic medication, pain management consultant from a physician, physical therapy, etc.).
Study: NCT06002880

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optibond Universal
Description: OBU™ will be used used for the cementation of indirect restorations (ceramic restorations, composite, zirconia and metal crowns) and pretreatment for indirect restoration, according to manufacturer's Instruction For Use in self-etch and total-etch modes.
Study: NCT06101784

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Avenanthramide
Description: In each cohort 6 subjects will be assigned to the active treatment and 2 subjects will be assigned to the placebo.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Avenanthramide
Description: In each cohort 6 subjects will be assigned to the active treatment and 2 subjects will be assigned to the placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In each cohort 6 subjects will be assigned to the active treatment and 2 subjects will be assigned to the placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: In each cohort 6 subjects will be assigned to the active treatment and 2 subjects will be assigned to the placebo.
Study: NCT05465317

Intervention type: DRUG
Intervention: Empagliflozin
Description: Empagliflozin

Intervention type: DRUG
Intervention: Dipeptidyl Peptidate-4 inhibitors
Description: Dipeptidyl Peptidate-4 inhibitors
Study: NCT05075980

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Proton Therapy
Description: Undergo IMPT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Proton Therapy
Description: Undergo IMPT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study: NCT06284720

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gamma tACS (40 Hz) over the precuneus
Description: 5 sessions of gamma tACS (40 Hz) over the precuneus

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tACS over the precuneus
Description: 5 sessions of sham tACS over the precuneus
Study: NCT03787082

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrates
Description: 1,000 mg/11.18 mmol, oral

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nitrates
Description: 1,000 mg/11.18 mmol, oral
Study: NCT05075980

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT or PET/CT
Study: NCT03787082

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Gluconate Mouthwash
Description: chlorhexidine gluconate 0.12% (15mL) mouth rinse for 1 minute

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Mouthwash
Description: sterile water (15mL) mouth rinse for 1 minute
Study: NCT05075980

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI or PET/MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI or PET/MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI or PET/MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT or PET/MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT or PET/MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT or PET/MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo IMRT
Study: NCT06478186

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: triamcinolone acetonide extended-release injectable suspension; TCA-ER
Description: Mode of Administration: IA Knee Injection Nominal 32 mg TCA, intra-articular (IA) injection, administered as a 5 mL injection

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone Acetonide- Immediate Release;TCA-IR
Description: Mode of Administration: IA Knee Injection Triamcinolone Acetonide- Immediate Release (TCA-IR)
Study: NCT05589662

Intervention type: OTHER
Intervention: Clinical and functional assessment
Description: The dependent variables (muscle strength, muscle activation, pressure pain threshold and joint status) and the outcome measures used to measure these variables will be: pressure dynamometer, surface electromyography, pressure algometer and Hemophilia Joint Health Score

Intervention type: OTHER
Intervention: Clinical and functional assessment
Description: The dependent variables (muscle strength, muscle activation, pressure pain threshold and joint status) and the outcome measures used to measure these variables will be: pressure dynamometer, surface electromyography, pressure algometer and Hemophilia Joint Health Score
Study: NCT06186570

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online-Based Self-Help Intervention
Description: See the description above.
Study: NCT05817058

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AFM28
Description: AFM28 dose escalation
Study: NCT05813236

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novosyn® in resective periodontal surgery
Description: The aim of resective procedures is the re-establishment of a healthy periodontium at a reduced level, accepting as irreversible the destruction that has already occurred. In essence, these procedures are all designed to achieve pocket elimination or reduction by the apical shift of the gingival margin.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Monosyn® in resective periodontal surgery
Description: The aim of resective procedures is the re-establishment of a healthy periodontium at a reduced level, accepting as irreversible the destruction that has already occurred. In essence, these procedures are all designed to achieve pocket elimination or reduction by the apical shift of the gingival margin.
Study: NCT04870047

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endovascular treatment of unruptured aneurysms with p64 MW HPC Flow Modulation Device
Description: Patients suffering from a distal intracranial aneurysm will be treated endovascularly with the p64 MW HPC Flow Modulation Device.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endovascular treatment of unruptured aneurysms with p64 MW HPC Flow Modulation Device
Description: Patients suffering from a distal intracranial aneurysm will be treated endovascularly with the p64 MW HPC Flow Modulation Device.
Study: NCT05318586

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: individual rTMS based on fNIRS
Description: The rTMS parameters will be set according to fNIRS results.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional rTMS strategy
Description: The low-frequency rTMS to contralesional M1 will always be used.
Study: NCT05574387

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin is an antidiabetic biguanide drug that acts by promoting glucose uptake and utilization in the liver.Recent studies proved that metformin could reduce colonic inflammation by AMPK-mediated inhibition of p38 mitogen-activated protein kinase (MAPK)
Study: NCT06338098

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 8-week wellness and relaxation meditation program
Description: Heartfulness Meditation program will be provided with guided meditation and relaxation audio clips to spend approximately 20 minutes per day on the meditation and relaxation activities and participate each week in a 20-30 minutes online meditation webinar with a certified meditation trainer. All meditation and relaxation exercises can be performed in the comfort of your own home or other place of your choosing. The intervention will be entirely online.
Study: NCT06492239

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Emergency Stroke Unit based on 0.23-T MRI
Description: The participants with hyperacute ischemic stroke (symptoms onset ≤4.5 h) who are eligible to receive reperfusion therapy will be managed by Emergency Stroke Unit process based on low-field magnetic resonance imaging.

Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Standard stroke unit adherent to guidelines
Description: The participants with hyperacute ischemic stroke (symptoms onset ≤4.5 h) who are eligible to receive reperfusion therapy will be managed by standard stroke unit process adherent to guidelines.
Study: NCT06184217

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental group (MSPE programme group).
Description: Experimental group. MSPE Programme. This group will receive a face-to-face mindfulness MSPE programme for 6 weeks, once a week for 1h 50min-2 hours. In addition to doing mindfulness activities at home. Each session contains the following exercises: (1) intention meditation, sultana exercise, diaphragmatic breathing and sitting meditation with a focus on breath, body and sound; (2) diaphragmatic breathing, Body Scan; (3) sitting meditation, dynamics of emotions, Mindful Yoga on the floor; (4) letting go of attachments, mindful Yoga on the floor walking meditation; (5) sports meditation, sitting meditation with a focus on breath, body and sound; (6) intention meditation, body scan analysis and review of sports meditation.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group (relaxation group).
Description: These instructions included a combination of tension-relaxation of specific muscles and simple breathing techniques. They were recommended to do this on a daily basis, with a minimum of 4 sessions per week.
Study: NCT05680402

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Soft Tissue mobilization
Description: mobilization of soft tissues of body

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Piriformis Syndrome (Piriformis muscle stretching)
Description: Stretching of Piriformis muscle
Study: NCT04800432

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ADAPT+
Description: ADAPT+ is designed as an 6-week intervention. For each session, children and parents participate in separate 1.5-hour group meetings, followed by a joint goal setting session. Practical strategies related to improving diet and physical activity as well as the role of dealing with parent stress-related factors related to making long-lasting behavioral changes in the family are addressed.
Study: NCT05110924

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of care
Description: Patients in the treatment arm will receive standard care.

Intervention type: OTHER
Group type: OTHER
Intervention: Monitoring
Description: Patients in the non-treatment arm will be closely monitored: the tumor will be evaluated using non-invasive imaging devices based on multispectral dermoscopy, reflectance confocal microscopy to determine the exact histology and high definition optical coherence tomography for imaging and volume calculation of the BCC.
Study: NCT05506124

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: airbag-type stretchable electrode array (ASEA) device
Description: Propose a novel airbag-type stretchable electrode array (ASEA) device for electrical stimulation for training of the female pelvic floor muscle (PFM) for the treatment of UI

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: two-channel hard electrode device
Description: Propose a two-channel hard electrode device for electrical stimulation for training of the female pelvic floor muscle (PFM) for the treatment of UI